Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationStem CellsTransplantation ConditioningLiver TransplantationBone Marrow TransplantationKidney TransplantationGraft SurvivalHematopoietic Stem Cell MobilizationTreatment OutcomeHematopoietic Stem CellsMultiple MyelomaImmunosuppressive AgentsGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideAntigens, CD34Graft RejectionEmbryonic Stem CellsHeart TransplantationAdult Stem CellsMesenchymal Stem Cell TransplantationRetrospective StudiesEtoposideAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsGranulocyte Colony-Stimulating FactorPluripotent Stem CellsTransplantation ChimeraCord Blood Stem Cell TransplantationTime FactorsStem Cell NicheCell DifferentiationNeural Stem CellsTissue DonorsCell TransplantationInduced Pluripotent Stem CellsMesenchymal Stromal CellsMyeloablative AgonistsMultipotent Stem CellsBusulfanRecurrenceHistocompatibility TestingWhole-Body IrradiationProspective StudiesStem Cell FactorRemission InductionMelphalanHistocompatibilityCell LineageGraft vs Leukemia EffectFetal Stem CellsCells, CulturedLeukemiaBone Marrow CellsDisease-Free SurvivalTransplantation ImmunologyVidarabineSurvival RateStem Cell ResearchSurvival AnalysisLung TransplantationHematopoiesisCell ProliferationLeukemia, Myeloid, AcuteFlow CytometryChimerismSalvage TherapyHepatic Veno-Occlusive DiseaseGraft vs Tumor EffectTransplantation, IsogeneicOrgan TransplantationHematologic DiseasesPlant StemsRegenerationHLA AntigensSiblingsLymphocyte TransfusionCell SeparationFollow-Up StudiesMyelodysplastic SyndromesMice, Inbred C57BLCell Culture TechniquesLymphoma, Non-HodgkinTransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplastic Stem CellsImmunosuppressionIslets of Langerhans TransplantationT-LymphocytesAntilymphocyte SerumPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionCytomegalovirus InfectionsCytarabinePrognosisLeukapheresis